These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 12901333

  • 1. Gene therapy for the hemoglobin disorders.
    Persons DA, Nienhuis AW.
    Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
    [Abstract] [Full Text] [Related]

  • 2. Update on gene therapy for hemoglobin disorders.
    Persons DA.
    Curr Opin Mol Ther; 2003 Oct; 5(5):508-16. PubMed ID: 14601520
    [Abstract] [Full Text] [Related]

  • 3. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G, Malik P.
    Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
    [Abstract] [Full Text] [Related]

  • 4. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M.
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [Abstract] [Full Text] [Related]

  • 5. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M, Rivella S, Lisowski L, Samakoglu S, Rivière I.
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
    [Abstract] [Full Text] [Related]

  • 6. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
    Lebensburger J, Persons DA.
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610
    [Abstract] [Full Text] [Related]

  • 7. Correction of sickle cell disease in transgenic mouse models by gene therapy.
    Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, Bouhassira EE, Acharya SA, Ellis J, London IM, Eaves CJ, Humphries RK, Beuzard Y, Nagel RL, Leboulch P.
    Science; 2001 Dec 14; 294(5550):2368-71. PubMed ID: 11743206
    [Abstract] [Full Text] [Related]

  • 8. Gene therapy for the hemoglobin disorders.
    Persons DA, Tisdale JF.
    Semin Hematol; 2004 Oct 14; 41(4):279-86. PubMed ID: 15508113
    [Abstract] [Full Text] [Related]

  • 9. Hemoglobin gene therapy for β-thalassemia.
    Bank A.
    Hematol Oncol Clin North Am; 2010 Dec 14; 24(6):1187-201. PubMed ID: 21075288
    [Abstract] [Full Text] [Related]

  • 10. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.
    Oh IH, Fabry ME, Humphries RK, Pawliuk R, Leboulch P, Hoffman R, Nagel RL, Eaves C.
    Exp Hematol; 2004 May 14; 32(5):461-9. PubMed ID: 15145214
    [Abstract] [Full Text] [Related]

  • 11. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.
    Nishino T, Tubb J, Emery DW.
    Blood Cells Mol Dis; 2006 May 14; 37(1):1-7. PubMed ID: 16814578
    [Abstract] [Full Text] [Related]

  • 12. Stem cell transplantation and gene therapy for hemoglobinopathies.
    Gaziev J, Lucarelli G.
    Curr Hematol Rep; 2005 Mar 14; 4(2):126-31. PubMed ID: 15720961
    [Abstract] [Full Text] [Related]

  • 13. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I.
    Ann N Y Acad Sci; 2005 Mar 14; 1054():78-91. PubMed ID: 16339654
    [Abstract] [Full Text] [Related]

  • 14. Modeling human hematopoietic stem cell gene therapy in nonhuman primates.
    Hematti P.
    Curr Hematol Rep; 2004 Jul 14; 3(4):282-9. PubMed ID: 15217558
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic globin gene delivery using lentiviral vectors.
    Rivella S, Sadelain M.
    Curr Opin Mol Ther; 2002 Oct 14; 4(5):505-14. PubMed ID: 12435053
    [Abstract] [Full Text] [Related]

  • 16. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P, Arumugam PI, Yee JK, Puthenveetil G.
    Ann N Y Acad Sci; 2005 Oct 14; 1054():238-49. PubMed ID: 16339671
    [Abstract] [Full Text] [Related]

  • 17. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA.
    Hematology Am Soc Hematol Educ Program; 2009 Oct 14; ():690-7. PubMed ID: 20008255
    [Abstract] [Full Text] [Related]

  • 18. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
    Bank A.
    Pediatr Hematol Oncol; 2008 Oct 14; 25(1):1-4. PubMed ID: 18231949
    [Abstract] [Full Text] [Related]

  • 19. Gene therapy for homozygous beta-thalassemia. Is it a reality?
    Boulad F, Rivière I, Sadelain M.
    Hemoglobin; 2009 Oct 14; 33 Suppl 1():S188-96. PubMed ID: 20001625
    [Abstract] [Full Text] [Related]

  • 20. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
    Samakoglu S, Lisowski L, Budak-Alpdogan T, Usachenko Y, Acuto S, Di Marzo R, Maggio A, Zhu P, Tisdale JF, Rivière I, Sadelain M.
    Nat Biotechnol; 2006 Jan 14; 24(1):89-94. PubMed ID: 16378095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.